Inventor · disambiguated record
Wei Hu
Also filed as: HU WEI · HU WEI-GANG
10 granted patents·10 pending applications·15 citations·filing 2007–2023
81Inventor score
Files withPRIMEGENE BEIJING CO LTD4HU WEI-GANG3CANADA MINISTER NAT DEFENCE2CHENGDU FENDI PHARMACEUTICAL CO LTD2BEIJING RECHSAND SCIENCE & TECH GROUP CO LTD1
Top patents by PatentIndex Score
20 records- 0185US9309211B2Arylalkene derivatives and use thereof as selective estrogen receptor modulatorsCENTAURUS BIOPHARMA CO LTD·Filed 2012·Granted Apr 12, 2016·11 cites·6 claims
- 0276US9309305B2Anti-ricin antibodies and uses thereofHU WEI-GANG·Filed 2012·Granted Apr 12, 2016·3 cites·6 claims
- 0370US8501157B2Humanized anti-Venezuelan equine encephalitis virus recombinant antibodiesHU WEI-GANG·Filed 2008·Granted Aug 6, 2013·1 cites·10 claims
- 0462US2025163055A1Polymorph of jak tyrosine kinase inhibitor and preparation method thereforPRIME GENE THERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 0560US2025282746A1Halogen-substituted isoindoline compound and use thereofCHENGDU FENDI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0657US10081672B2Anti-ricin antibodies and uses thereofCANADA MINISTER NAT DEFENCE·Filed 2016·Granted Sep 25, 2018·0 cites·10 claims
- 0757US2024368113A1Amide compound and use thereofCHENGDU FENDI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0851US2023303578A1Preparation method for pyrrolopyrimidine compoundPRIMEGENE BEIJING CO LTD·Filed 2021·Application pending·0 cites
- 0950US2024132517A1Macrocyclic compound, pharmaceutical composition, and use thereofGOHARMONY THERAPEUTICS SHENZHEN CO LTD·Filed 2022·Application pending·0 cites
- 1049US9982040B2Anti-ricin antibodies and uses thereofCANADA MINISTER NAT DEFENCE·Filed 2016·Granted May 29, 2018·0 cites·14 claims
- 1147US8309090B2Monoclonal antibodies for neutralizing anthrax toxinHU WEI-GANG·Filed 2009·Granted Nov 13, 2012·0 cites·8 claims
- 1246US12404275B2Pyrazolopyrazine derived compounds, pharmaceutical composition and use thereofPRIMEGENE BEIJING CO LTD·Filed 2020·Granted Sep 2, 2025·0 cites·12 claims
- 1346US2009117105A1Humanized anti-venezuelan equine encephalitis virus recombinant antibodyCA MINISTER NAT DEFENCE·Filed 2007·Application pending·0 cites
- 1445US2025295628A1Highly stable heavy metal-removing composition, use and dosage form thereof, and preparation method thereforGUANGDONG JIANERSHENG PHARMACEUTICAL TECH CO LTD·Filed 2022·Application pending·0 cites
- 1544US2022387435A1Use of multi-target protein kinase inhibitorCSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD·Filed 2020·Application pending·0 cites
- 1643US12304898B2Quinolyl-containing compound and pharmaceutical composition, and use thereofPRIMEGENE BEIJING CO LTD·Filed 2020·Granted May 20, 2025·0 cites·10 claims
- 1742US12129258B2Diaryl macrocyclic compound and pharmaceutical composition, and use thereofPRIMEGENE BEIJING CO LTD·Filed 2019·Granted Oct 29, 2024·0 cites·7 claims
- 1833US9540396B26-arylamino pyridone carboxamide as MEK inhibitorsXIAO DENGMING·Filed 2011·Granted Jan 10, 2017·0 cites·10 claims
- 1933US2016158307A1Potent and Efficient Cytotoxic Peptides and Antibody-Drug Conjugates thereof and Their SynthesisHU SHANGHUI·Filed 2016·Application pending·0 cites
- 2028US2017145302A1Self-suspending proppant and preparation and use thereofBEIJING RECHSAND SCIENCE & TECH GROUP CO LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wei Hu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →